The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature.
Grossman. A A; Savage. M O MO; Blacklay. A A; Ross. R M RM; Plowman. P N PN; Preece. M A MA; Coy. D H DH; Besser. G M GM
Key Findings
- A single 200 µg IV dose of GHRH raised GH to normal or near‑normal levels in many children with various types of growth‑hormone deficiency.
- Continuous infusions and twice‑daily sub‑Q injections of GHRH maintained elevated GH for up to two weeks.
- Even children who had brain radiation for tumors responded to GHRH, indicating the peptide works across different causes of deficiency.
Practical Outcomes
- For biohackers, the data confirm that GHRH can stimulate GH production, but the dosing regimens used were medical‑grade and tested only in deficient children. There’s no direct evidence it’s safe or effective for healthy adults seeking longevity or performance gains, so any self‑experiment should proceed with extreme caution and medical oversight.
Summary
The study shows that giving a synthetic version of growth‑hormone‑releasing hormone (GHRH) can quickly raise growth hormone levels in kids who have a deficiency, and that regular dosing keeps the hormone elevated over days. However, the research was done in children with medical growth problems, not in healthy adults looking for performance or anti‑aging benefits.
Abstract
We have assessed the role of growth hormone-releasing hormone (GHRH) as a diagnostic test in 40 children and young adults with growth hormone deficiency (GHD), principally using the GHRH(1-29)NH2 analogue. Following 200 micrograms GHRH as an acute intravenous bolus, serum GH rose to normal or just subnormal levels in 13 out of 17 children with structural lesions, and in 8 of 14 patients with idiopathic GHD or panhypopituitarism. Of 9 children (mean age 12 years) with GHD following treatment with cranial irradiation for nonendocrine tumours, all responded acutely to GHRH. 12- and 24-hour infusions with GHRH(1-29)NH2, and 1- and 2-week treatments with twice-daily subcutaneous GHRH(1-29)NH2, showed persistent stimulation of GH release. It is concluded that many children with GHD of diverse aetiology will respond both acutely and chronically to treatment with GHRH.
Study Information
pubmed
1985
10.1159/000180071
27